{"transactions":[{"id":741445,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:07:57.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":37000,"derivative":{"exercise_price":2.46,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001193125-26-267521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000119312526267521/ownership.xml","form_type":"4"}},{"id":749658,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-04T20:19:18.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 3, 2026. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 3, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":9000,"derivative":{"exercise_price":4.72,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001193125-26-257445","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526257445/ownership.xml","form_type":"4"}},{"id":944225,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Bus & Fin Officer"}}],"security":"Common Stock","published_at":"2026-01-08T00:37:56.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":459,"price":10.55,"value":4842.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock purchased pursuant to the Issuer's Amended and Restated Employee Stock Purchase Plan (ESPP) for the ESPP purchase period July 1, 2025 through December 31, 2025.  In accordance with the ESPP, the shares of common stock were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025."}],"balance_after":459,"source":{"system":"sec-edgar","filing":"0001193125-26-006727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000119312526006727/ownership.xml","form_type":"4"}},{"id":1117649,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:01:49.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 5, 2026 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":46000,"derivative":{"exercise_price":1.83,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0000950170-25-083681","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000095017025083681/ownership.xml","form_type":"4"}},{"id":1173313,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-11T20:48:34.000Z","date":"2025-04-10","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on April 10, 2025. The shares underlying the option are scheduled to vest over three years in equal monthly installments from April 3, 2025 through April 3, 2028, subject to continuous service."}],"balance_after":18000,"derivative":{"exercise_price":7.31,"expiration_date":"2035-04-09","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000950170-25-053330","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025053330/ownership.xml","form_type":"4"}},{"id":1305011,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Bus & Fin Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-10T23:11:32.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":53000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs vest in three equal annual installments beginning on first anniversary of grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs vest in three equal annual installments beginning on first anniversary of grant date."}],"balance_after":53000,"derivative":{"underlying":"Common Stock","underlying_shares":53000},"source":{"system":"sec-edgar","filing":"0000950170-25-004358","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000095017025004358/ownership.xml","form_type":"4"}},{"id":1305010,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Bus & Fin Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-10T23:11:32.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":79000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date."}],"balance_after":79000,"derivative":{"exercise_price":13.22,"expiration_date":"2035-01-09","underlying":"Common Stock","underlying_shares":79000},"source":{"system":"sec-edgar","filing":"0000950170-25-004358","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000095017025004358/ownership.xml","form_type":"4"}},{"id":1417541,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Bus & Fin Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-03T21:50:06.000Z","date":"2024-09-01","kind":"grant","planned":false,"acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date."}],"balance_after":360000,"derivative":{"exercise_price":11.73,"expiration_date":"2034-08-31","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0000950170-24-102982","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000095017024102982/ownership.xml","form_type":"4"}},{"id":1478757,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:09:03.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 13, 2025 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":22500,"derivative":{"exercise_price":6.23,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-24-073643","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000095017024073643/ownership.xml","form_type":"4"}},{"id":1615197,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. and Bus. Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-28T00:29:46.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":205000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":205000,"derivative":{"exercise_price":5.22,"exercise_date":"2024-03-23","expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":205000},"source":{"system":"sec-edgar","filing":"0000950170-24-021547","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000095017024021547/ownership.xml","form_type":"4"}},{"id":1615196,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. and Bus. Officer"}}],"security":"Common Stock","published_at":"2024-02-28T00:29:46.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2024, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 75,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":95755,"source":{"system":"sec-edgar","filing":"0000950170-24-021547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000095017024021547/ownership.xml","form_type":"4"}},{"id":1637917,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. and Bus. Officer"}}],"security":"Common Stock","published_at":"2024-02-17T01:32:46.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":5201,"price":5.86,"value":30477.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $5.61 to $6.15. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 40,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,414 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2023."}],"balance_after":60755,"source":{"system":"sec-edgar","filing":"0000950170-24-016667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000095017024016667/ownership.xml","form_type":"4"}},{"id":1801718,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. and Bus. Officer"}}],"security":"Common Stock","published_at":"2023-08-18T22:31:38.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":4452,"price":3.81,"value":16962.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.76 to $3.87. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 52,500 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,994 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2023."}],"balance_after":64542,"source":{"system":"sec-edgar","filing":"0001209191-23-046640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919123046640/doc4.xml","form_type":"4"}},{"id":1860314,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T20:07:40.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 7, 2024 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":22500,"derivative":{"exercise_price":4.86,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-23-035750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919123035750/doc4.xml","form_type":"4"}},{"id":2007063,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. and Bus. Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-02-17T23:45:01.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":190000,"derivative":{"exercise_price":3.06,"exercise_date":"2023-03-15","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001209191-23-010881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919123010881/doc4.xml","form_type":"4"}},{"id":2007062,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. and Bus. Officer"}}],"security":"Common Stock","published_at":"2023-02-17T23:45:01.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F4","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the total number of shares subject to the restricted stock unit award on each of August 15, 2023, February 15, 2024, August 15, 2024 and February 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 65,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":67000,"source":{"system":"sec-edgar","filing":"0001209191-23-010881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919123010881/doc4.xml","form_type":"4"}},{"id":2007061,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. and Bus. Officer"}}],"security":"Common Stock","published_at":"2023-02-17T23:45:01.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on the six month anniversary of the Transaction Date, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 30,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 2,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2022."}],"balance_after":32000,"source":{"system":"sec-edgar","filing":"0001209191-23-010881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919123010881/doc4.xml","form_type":"4"}},{"id":2235679,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:08:11.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 8, 2023 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":16000,"derivative":{"exercise_price":14.95,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-22-035828","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919122035828/doc4.xml","form_type":"4"}},{"id":2249290,"issuer":{"id":5064,"kind":"organization","name":"Climb Bio, Inc.","symbol":"CLYM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2022-06-01T21:12:18.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of May 19, 2023 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date."}],"balance_after":10000,"derivative":{"exercise_price":3.46,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-033217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919122033217/doc4.xml","form_type":"4"}},{"id":2387981,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. and Bus. Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-02-17T22:41:29.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one (1) month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":66000,"derivative":{"exercise_price":15.19,"exercise_date":"2022-03-15","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":66000},"source":{"system":"sec-edgar","filing":"0001209191-22-010920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919122010920/doc4.xml","form_type":"4"}},{"id":2667989,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T14:26:26.000Z","date":"2021-06-13","kind":"grant","acquired":true,"shares":16511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":16511,"derivative":{"exercise_price":25.03,"expiration_date":"2031-06-12","underlying":"Common Stock","underlying_shares":16511},"source":{"system":"sec-edgar","filing":"0000899243-21-023798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000089924321023798/doc4.xml","form_type":"4"}},{"id":2849409,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T02:03:54.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of February 16, 2021 (the \"Vesting Commencement Date\"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":240000,"derivative":{"exercise_price":13.44,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001209191-21-012211","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919121012211/doc4.xml","form_type":"4"}},{"id":2866269,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2021-02-12T00:47:09.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":62,"price":14.1393,"value":876.6366,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to an irrevocable election previously made by the Reporting Person to sell shares of common stock necessary to cover the federal, state and local tax withholding obligations, as well as related brokerage commission fees."}],"balance_after":97955,"source":{"system":"sec-edgar","filing":"0001209191-21-009908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919121009908/doc4.xml","form_type":"4"}},{"id":2866268,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CFO"}}],"security":"Common Stock","published_at":"2021-02-12T00:47:09.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":12471,"price":14.1,"value":175841.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to an irrevocable election previously made by the Reporting Person to sell shares of common stock necessary to cover the federal, state and local tax withholding obligations, as well as related brokerage commission fees."}],"balance_after":98017,"source":{"system":"sec-edgar","filing":"0001209191-21-009908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919121009908/doc4.xml","form_type":"4"}},{"id":3084226,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-14T01:42:17.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":18300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares subject to the option vest 100% on the first anniversary of July 1, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":18300,"derivative":{"exercise_price":18,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":18300},"source":{"system":"sec-edgar","filing":"0000899243-20-019026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000089924320019026/doc4.xml","form_type":"4"}},{"id":3084225,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-14T01:42:17.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":10700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first anniversary of July 9, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":10700,"derivative":{"exercise_price":18,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":10700},"source":{"system":"sec-edgar","filing":"0000899243-20-019026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000089924320019026/doc4.xml","form_type":"4"}},{"id":3106704,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-06-17T21:47:11.000Z","date":"2020-06-16","kind":"sale","acquired":false,"shares":13171,"price":24.68,"value":325060.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to an irrevocable election previously made by the Reporting Person to sell shares of common stock necessary to cover the federal, state and local tax withholding obligations, as well as related brokerage commission fees."}],"balance_after":110488,"source":{"system":"sec-edgar","filing":"0001209191-20-037369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120037369/doc4.xml","form_type":"4"}},{"id":3156173,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-08T22:25:38.000Z","date":"2020-05-06","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-Five Percent (25%) of the total shares subject to the option vest and become exercisable on the first anniversary of the Vesting Commencement Date, and 1/48 of the total shares subject to the option shall vest and become exercisable each month thereafter, such that all of the shares subject to the option shall be vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":155576,"derivative":{"exercise_price":3.44,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-028070","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120028070/doc4.xml","form_type":"4"}},{"id":3156172,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-05-08T22:25:38.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":20000,"price":20.02,"value":400400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was pursuant to a 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price. The shares were sold at prices ranging from $20.00 to $20.09. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The balance of shares reflected in Reporting Person's prior Form 4 was inadvertently reflected as 123,429 shares and should have been reflected as 123,659 shares.  The Form 4 originally reflecting the incorrect balance, filed with the SEC on 2/10/2020, has been amended to reflect the correct end of period balance in Column 5 of Table I in that filing."}],"balance_after":123659,"source":{"system":"sec-edgar","filing":"0001209191-20-028070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120028070/doc4.xml","form_type":"4"}},{"id":3156171,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-05-08T22:25:38.000Z","date":"2020-05-06","kind":"exercise","acquired":true,"shares":20000,"price":3.44,"value":68800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The balance of shares reflected in Reporting Person's prior Form 4 was inadvertently reflected as 123,429 shares and should have been reflected as 123,659 shares.  The Form 4 originally reflecting the incorrect balance, filed with the SEC on 2/10/2020, has been amended to reflect the correct end of period balance in Column 5 of Table I in that filing."}],"balance_after":143659,"source":{"system":"sec-edgar","filing":"0001209191-20-028070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120028070/doc4.xml","form_type":"4"}},{"id":3156168,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-05-08T22:24:39.000Z","date":"2020-02-09","kind":"tax_withholding","acquired":false,"shares":10985,"price":10.24,"value":112486.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares withheld by the Issuer upon vesting of restricted stock units to satisfy withholding tax obligations."}],"balance_after":139235,"source":{"system":"sec-edgar","filing":"0001209191-20-028067","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120028067/doc4a.xml","form_type":"4/A","original_submission_date":"2020-02-10"}},{"id":3195112,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-25T21:28:50.000Z","date":"2020-03-20","kind":"exercise","acquired":false,"shares":24424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five Percent (25%) of the total shares subject to the option vest and become exercisable on the first anniversary of the Vesting Commencement Date, and 1/48 of the total shares subject to the option shall vest and become exercisable each month thereafter, such that all of the shares subject to the option shall be vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":175576,"derivative":{"exercise_price":3.44,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":24424},"source":{"system":"sec-edgar","filing":"0001209191-20-021159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120021159/doc4.xml","form_type":"4"}},{"id":3195111,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-03-25T21:28:50.000Z","date":"2020-03-20","kind":"sale","acquired":false,"shares":39526,"price":10.1682,"value":401908.2732,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was pursuant to a 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price. The shares were sold at prices ranging from $10.00 to $10.58. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":123429,"source":{"system":"sec-edgar","filing":"0001209191-20-021159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120021159/doc4.xml","form_type":"4"}},{"id":3195110,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-03-25T21:28:50.000Z","date":"2020-03-20","kind":"exercise","acquired":true,"shares":24424,"price":3.44,"value":84018.56,"ownership":{"direct":true},"balance_after":162955,"source":{"system":"sec-edgar","filing":"0001209191-20-021159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120021159/doc4.xml","form_type":"4"}},{"id":3202142,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-03-18T23:33:40.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":474,"price":10.0195,"value":4749.243,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was pursuant to a 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price. The shares were sold at prices ranging from $10.01 to $10.03. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":138531,"source":{"system":"sec-edgar","filing":"0001209191-20-020107","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120020107/doc4.xml","form_type":"4"}},{"id":3256069,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-22T00:15:35.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of February 20, 2020 (the \"Vesting Commencement Date\"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":15.75,"expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-20-011783","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120011783/doc4.xml","form_type":"4"}},{"id":3281841,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-02-10T12:56:41.000Z","date":"2020-02-09","kind":"tax_withholding","acquired":false,"shares":11215,"price":10.24,"value":114841.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares withheld by the Issuer upon vesting of restricted stock units to satisfy withholding tax obligations."}],"balance_after":139005,"source":{"system":"sec-edgar","filing":"0001209191-20-007758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120007758/doc4.xml","form_type":"4"}},{"id":3281842,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-02-10T12:54:06.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":40000,"price":10.72,"value":428800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was pursuant to a 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price. The shares were sold at prices ranging from $10.30 to $11.055. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This Form 4 amendment is being filed solely to correct the number of shares held by the undersigned following this transaction."}],"balance_after":150220,"source":{"system":"sec-edgar","filing":"0001209191-20-007756","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120007756/doc4a.xml","form_type":"4/A","original_submission_date":"2019-12-26"}},{"id":3281840,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-02-10T12:51:14.000Z","date":"2019-06-15","kind":"tax_withholding","acquired":false,"shares":35282,"price":10.82,"value":381751.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitutes shares withheld to cover withholding tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not tie to prior filings as the prior filings did not take into account this transaction.  The Form 4 for the latest transaction by the undersigned will be amended to reflect the then current ownership following the transaction reported on that latest filing."}],"balance_after":190220,"source":{"system":"sec-edgar","filing":"0001209191-20-007754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120007754/doc4.xml","form_type":"4"}},{"id":3281839,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-02-10T12:51:14.000Z","date":"2019-06-15","kind":"tax_withholding","acquired":false,"shares":8570,"price":10.82,"value":92727.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitutes shares withheld to cover withholding tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not tie to prior filings as the prior filings did not take into account this transaction.  The Form 4 for the latest transaction by the undersigned will be amended to reflect the then current ownership following the transaction reported on that latest filing."}],"balance_after":225502,"source":{"system":"sec-edgar","filing":"0001209191-20-007754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120007754/doc4.xml","form_type":"4"}},{"id":3281838,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-02-10T12:51:14.000Z","date":"2019-02-09","kind":"tax_withholding","acquired":false,"shares":8176,"price":3.33,"value":27226.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitutes shares withheld to cover withholding tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not tie to prior filings as the prior filings did not take into account this transaction.  The Form 4 for the latest transaction by the undersigned will be amended to reflect the then current ownership following the transaction reported on that latest filing."}],"balance_after":234072,"source":{"system":"sec-edgar","filing":"0001209191-20-007754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120007754/doc4.xml","form_type":"4"}},{"id":3281837,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-02-10T12:51:14.000Z","date":"2018-06-15","kind":"tax_withholding","acquired":false,"shares":8645,"price":5.55,"value":47979.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitutes shares withheld to cover withholding tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not tie to prior filings as the prior filings did not take into account this transaction.  The Form 4 for the latest transaction by the undersigned will be amended to reflect the then current ownership following the transaction reported on that latest filing."}],"balance_after":242248,"source":{"system":"sec-edgar","filing":"0001209191-20-007754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120007754/doc4.xml","form_type":"4"}},{"id":3281836,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-02-10T12:51:14.000Z","date":"2018-02-09","kind":"tax_withholding","acquired":false,"shares":8208,"price":7.05,"value":57866.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitutes shares withheld to cover withholding tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not tie to prior filings as the prior filings did not take into account this transaction.  The Form 4 for the latest transaction by the undersigned will be amended to reflect the then current ownership following the transaction reported on that latest filing."}],"balance_after":162397,"source":{"system":"sec-edgar","filing":"0001209191-20-007754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120007754/doc4.xml","form_type":"4"}},{"id":3281835,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2020-02-10T12:51:14.000Z","date":"2017-06-15","kind":"tax_withholding","acquired":false,"shares":9395,"price":2.7,"value":25366.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitutes shares withheld to cover withholding tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not tie to prior filings as the prior filings did not take into account this transaction.  The Form 4 for the latest transaction by the undersigned will be amended to reflect the then current ownership following the transaction reported on that latest filing."}],"balance_after":170605,"source":{"system":"sec-edgar","filing":"0001209191-20-007754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919120007754/doc4.xml","form_type":"4"}},{"id":3331095,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2019-12-26T21:47:06.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":40000,"price":10.72,"value":428800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was pursuant to a 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price. The shares were sold at prices ranging from $10.30 to $11.055. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":228496,"source":{"system":"sec-edgar","filing":"0001209191-19-061950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919119061950/doc4.xml","form_type":"4"}},{"id":3649307,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-19T21:15:52.000Z","date":"2019-02-14","kind":"grant","acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of February 14, 2019 (the \"Vesting Commencement Date\"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":800000,"derivative":{"exercise_price":3.5,"expiration_date":"2028-02-13","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001209191-19-011063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919119011063/doc4.xml","form_type":"4"}},{"id":3785804,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-22T20:17:29.000Z","date":"2018-10-18","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of October 18, 2018 (the \"Vesting Commencement Date\"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":4.7,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-055834","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919118055834/doc4.xml","form_type":"4"}},{"id":3890470,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO, Interim Pres and CEO"}}],"security":"Common Stock","published_at":"2018-06-18T20:37:37.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":88496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of Common Stock of the Issuer for each one (1) RSU upon the vesting thereof. Such RSUs vest with respect to 100% of the shares on June 15, 2019, subject to the Reporting Person's continued service with the Issuer on the applicable vesting date."}],"balance_after":268496,"source":{"system":"sec-edgar","filing":"0001209191-18-038333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919118038333/doc4.xml","form_type":"4"}},{"id":4047148,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-21T00:17:51.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of February 15, 2018 (the \"Vesting Commencement Date\"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":6.4,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001209191-18-011603","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919118011603/doc4.xml","form_type":"4"}},{"id":4453593,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-13T22:43:03.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":116000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of the Vesting Commencement Date, and 1/48th of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":116000,"derivative":{"exercise_price":2.7,"expiration_date":"2027-02-08","underlying":"Common Stock","underlying_shares":116000},"source":{"system":"sec-edgar","filing":"0001209191-17-010118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919117010118/doc4.xml","form_type":"4"}},{"id":4453592,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":39209,"kind":"person","name":"PATTERSON LEONE D","position":1,"cik":"0001233539","reported_name":"PATTERSON LEONE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2017-02-13T22:43:03.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of Common Stock of the Issuer for each one (1) RSU upon the vesting thereof. Such RSUs vest with respect to 25% of the shares subject thereto on each anniversary of February 9, 2017 (the \"Vesting Commencement Date\"), such that all of the shares subject to the RSUs shall be vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":180000,"source":{"system":"sec-edgar","filing":"0001209191-17-010118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233539/000120919117010118/doc4.xml","form_type":"4"}}]}